Objective: To examine the feasibility of a real "blood transfusion"free hepatectomy in a large group of patients with liver tumors. Summary Background Data: Bleeding control and blood transfusion remains problematic in liver resection. A real "blood transfusion"-free hepatectomy in a large group of patients has rarely been reported. The impact of tranexamic acid (TA), an antifibrinolytic agent, on blood transfusion in liver resection is unknown. Methods: A prospective double-blind randomized trial was performed on elective liver tumor resections. In group A, TA 500 mg was intravenously administered just before operation followed by 250 mg, every 6 hours, for 3 days. In group B, only placebo was given. The patients' background, blood transfusion rates, and early postoperative results in the 2 groups were compared. Factors that influenced blood requirement were analyzed. Results: There were 108 hepatectomies in group A and 106 hepatectomies in group B. The patients' backgrounds, operative procedures, and hepatectomy extent did not significantly differ between the 2 groups. Although the differences of the operative morbidity and postoperative stay were not significant, a significantly lower amount of operative blood loss, lower blood transfusion rate, shorter operative time, and lower hospital costs were found in group A patients. No patient in group A received blood transfusion. No hospital mortality occurred in either group. Tumor size and use of TA were independent factors that influenced blood transfusion. Conclusions: Perioperative parenteral use of TA reduced the amount of operative blood loss and the need for blood transfusion in elective liver tumor resection. A real "blood transfusion"-free hepatectomy may be feasible with the assistance of parenteral TA. (Ann Surg 2006;243: 173-180) From the Department of *Surgery, †Anesthesiology, and ‡Pathology, Taichung
L iver resection remains a main option for primary or metastatic liver malignancies, benign liver tumors, and some biliary diseases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] However, liver resection is still a complex procedure and should be performed in high-volume centers. 21 With advances in perioperative assessments and surgical equipment, the safety of liver resection improved. 2, 4, 5, 13 A total of 1056 consecutive liver resections without operative mortality has even been reported recently. 5 It is well known that a hyperfibrinolytic state may occur after liver resection or liver trauma. [22] [23] [24] Hemorrhage is still a major problem in liver resection at present. Homologous blood transfusion is inevitable if blood loss threatens vital signs. 2, 3, 15 However, blood transfusion may transmit some infectious diseases, increase postoperative morbidity and mortality, and cause a poor prognosis of primary and secondary liver malignancies. 4 -13,20 A bloodless hepatectomy to avoid blood transfusion was first considered a realistic objective in the late 1980s. 3, 9, 10 Many strategies or operative devices were proposed to approach the goal of a "blood transfusion"-free hepatectomy. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] With these new devices and strategies, the amount of operative bleeding markedly reduced, and the rate of blood transfusion in liver resection was substantially reduced. 1,2,4 -8,11-13,20 Donor hepatectomy in living donor liver transplantation is usually performed without blood transfusion. 1, 4, 5, 25 The liver parenchyma of the living donors is unexceptionally normal. 4, 5, 25 In recent reports, a total "blood transfusion"-free liver resection was performed. 11, 12, 20 However, patient numbers in these reports 11, 12, 20 were limited, and the liver parenchyma of the majority of the patients was rarely abnormal.
Tranexamic acid (TA), 4-aminomethyl-cyclohexanecarboxylic acid, a synthetic derivative of the amino-acid lysine, has been reported to reduce bleeding in many surgical procedures, such as arthroplasty, cardioaortic surgery under cardiopulmonary bypass, and in liver transplantation by its antifibrinolytic effect. 26 -32 TA prevents the plasmin-mediated conversion of fibrinogen to fibrinogen split products by inhibition of the lysine-binding sites on plasminogen molecules, thus blocking fibrinolysis. 26 -29 It also inhibits plasminogen and plasmin at platelets and exerts a protective effect on platelets. 26 -32 Another antifibrinolytic agent, aprotinin, a nonspecific serine protease inhibitor derived from bovine lung with a great affinity for plasmin and low affinity for kallikrein, can reduce platelet dysfunction, thereby inhibiting fibrinolysis. 24, 28, 29 Aprotinin has been reported, effective reducing blood transfusion in the aforementioned surgical procedures. 24, 28, 29 It is also effective in reducing operative blood loss and blood transfusion after liver resection. 24 TA is much cheaper than aprotinin, 28, 29 but its antifibrinolytic effect in liver resection has never been reported. As a tertiary referral center in an endemic area of hepatitis B, we frequently resected liver tumor in diseased livers. [13] [14] [15] 33 In this study, a prospective double-blind, randomized trial of perioperative parenteral TA in liver resection was carried out to evaluate the influence of blood transfusion of this drug on liver resection. The feasibility of "blood transfusion"-free hepatectomy in a large group of patients was also examined.
MATERIALS AND METHODS
A total of 212 patients who underwent 217 consecutive liver resections for various liver tumors within a 32-month period between January 2002 and August 2004 were included in this study. Among them, 101 hepatectomies were performed for asymptomatic tumors. None of the patients enrolled in this study had anemia (hemoglobin Ͻ8.0 g/dL), history of thrombotic disease, or end-stage renal failure. 26 The liver tumors included in this study were mostly primary or metastatic liver cancer, either newly diagnosed or recurrent cases, and some benign liver tumors. Patients who underwent emergency surgery for a ruptured liver tumor or patients whose liver tumors were resected under cardiopulmonary bypass 33 were excluded from the study.
Preoperative Assessments
Patients who were admitted for liver tumor resection received conventional liver function tests, prothrombin time examination (shown as international normalized ratio), indocyanine green (ICG) clearance test, and imaging studies for liver tumors (including abdominal ultrasonography, computed tomography, and/or angiography). [13] [14] [15] 34 The extent of liver resection was determined by the tumor location, liver function, and ICG 15-minute retention rate (ICG R-15). [13] [14] [15] Concomitant splenectomy was carried out in cirrhotic patients with hypersplenic thrombocytopenia. 13 Endoscopic sclerotherapy was performed on cirrhotic patients with severe esophageal varices before operation. 13 Child-Pugh grading for liver function 34 was applied to patients with chronic hepatitis or cirrhosis. Couinaud's definition of liver segments 35 and Brisbane nomenclature of liver anatomy and resection 36 were used to demonstrate the tumor location and type of liver resection.
Randomization
When the liver tumor was judged as resectable after preoperative assessments, these operations were randomized into 2 groups 1 day before operation. The randomization was double-blinded in a sealed envelope. In group A, 109 operations, intravenous TA (transamin, Daiichi, Japan), 500 mg, was administered just before operation. Thereafter, patients received 250 mg of this drug every 6 hours for 3 days. In group B, which comprised 108 hepatectomies, a similar volume of normal saline was used as a placebo at the same time interval as TA injection. Neither surgeons nor medical staffs knew whether patients were enrolled in group A or group B. This study was approved by the ethical committee of the hospital. Informed consent was obtained from every patient before randomization.
Intraoperative Strategies and Operative Procedures
Operation was performed under general anesthesia with endotracheal intubation. 13 All operations were performed or guided by the same surgeon (C.-C.W.). Central venous line, peripheral arterial line, and urethral catheter were routinely set up for intraoperative monitoring vital signs and urine output. [13] [14] [15] Abdominal incision was usually made by a right upper abdominal J-shaped incision unless in the presence of previous upper abdominal operative scar. 5, 20 An inverted T-incision over upper abdomen was usually needed when concomitant splenectomy was required. Before liver resection, cholecystectomy was routinely performed if the gallbladder was not previously removed. [13] [14] [15] Intraoperative ultrasonography 4, 5, 20 was routinely performed. Liver parenchyma was transected using a Kelly hemostatic clamp. 5, [13] [14] [15] 18, 20 The intrahepatic vasculatures (including blood vessels and bile ducts) of the conserved side were ligated or sutured with fine silks. In the tumor side, these vessels were closed by silks or metallic hemoclips. 7, 14, 15 Other liver transection devices (such as ultrasonic dissector, microwave, cryosurgical machine, water jet, or radiofrequency apparatus [7] [8] [9] [10] [11] [12] 18, 19 ) were not used in this series.
Except in 4 hepatectomies (2 in each group, performed for small tumor located near the left triangular ligament or at the peripheral part of segment 6), intermittent hepatic inflow occlusion, by total or hemihepatic technique, was performed during liver parenchymal transection if necessary. 2, 5, [13] [14] [15] 20 Hydrocortisone, 200 mg, was intravenously administered before hepatic inflow occlusion. 5, [13] [14] [15] 20 Total clamping of liver pedicle (Pringle maneuver) was performed by a Satinsky vascular clamp for 15 minutes and declamping for 5 minutes. 5, [13] [14] [15] 20 Hemihepatic clamp technique was carried out in 28 operations (15 in group A, 13 in group B) requiring complex central liver resections. 14 The clamping and declamping duration in each cycle of hemihepatic clamp technique was 30 minutes and 5 minutes, respectively. 5, 14 During the declamping period, the liver transection plane was packed with dry gauzes by bimanual compression for temporary hemostasis. [13] [14] [15] The inflow blood occlusion was maintained until all bleeding points from hepatic veins on the liver cut surface were checked. 7, 14, 15 Then the bleeding points from hepatic artery and portal vein on the liver cut surface were meticulously sutured after removal of the specimens. 14, 15 Thereafter, the area of the liver cut surface was estimated by measuring the rinsed area by putting a dry gauze on the cut surface. 2, 14, 15 The cut surface was packed with Surgicel (an absorbable oxidized regenerated cellulose, Ethicon, Somerville, NJ). [13] [14] [15] Soft drains were placed around the cut surface before closure of the wound. [13] [14] [15] 20 The operation time was counted from skin incision to skin closure. The operative bleeding amount was determined by assessing the sum of blood volume in the suction bottle and the amount of blood in the soaked gauze. The blood loss from the beginning of liver parenchymal transection to total hemostasis of the liver cut surface was defined as blood loss in liver parenchymal transection. The blood loss from skin incision to liver parenchymal transection and from complete hemostasis of liver cut surface to complete skin closure were measured as blood loss in other procedures (including liver mobilization, additional procedures, etc). Central venous pressure was kept around 5 cm H 2 O by a senior anesthesiologist (W.-M.H.) during liver parenchymal transection. 7, 8, [13] [14] [15] 20, 37 Concomitant adjacent organ resections were carried out for total removal of liver malignancies. 13, 14 Total vascular exclusion technique, cell saver, autologous blood storage, and intraoperative hemodilution procedures 6 -8,16,17 were not used in this study. Blood transfusion was performed when the hematocrit was Ͻ24% or Ͻ27% in aged patients under a restrictive blood transfusion policy. 4, 5, [13] [14] [15] 20 
Postoperative Assessments
After operation, intravenous dopamine, 5 g/kg body weight, was administered until bowel function was restored. 7, 13 Proton pump inhibitors were used in patients with peptic ulcer. The perihepatic drains were usually removed on postoperative days 3 to 5, provided that there was no bile leakage or abscess formation. [13] [14] [15] The resected specimens were sent to a pathologist (M.-C.W.) for histologic confirmation. The tumor size was defined as the largest diameter of the tumor. In patients with multiple tumors, the tumor size was defined as the diameter of the largest tumor. 4, 5 Postoperative morbidity and mortality were defined as complications and death that occurred after operation within the same hospitalization. 1,2,4,6 -12 The histology of nontumorous liver parenchyma was defined as normal, chronic hepatitis or cirrhosis according to the definition proposed by Anthony et al. 38 
Statistical Analysis
The continuous variables were presented as median (range) and compared using Mann-Whitney U test. The frequencies were compared by Pearson's 2 test or 2-tailed Fisher exact test as appropriate. P values Ͻ0.05 were considered significant. The perioperative clinicopathologic variables that influence the blood transfusion rate in liver resection were analyzed. To determine the independent factors that influenced the blood requirement, a multivariate analysis of the preresectional variables whose P values were Ͻ0.1 in univariate analysis was carried out using a backward stepwise logistic regression model. Statistical analyses were performed using commercially available software (SPSS/PCϩ SPSS, Chicago, IL).
RESULTS
After laparotomy, liver resection in 3 operations (1.4%) was not completed because of discovery of diffuse peritoneal metastases in 2 patients (1 in each group) and a bilobar multiple tumors in 1 group B patient. Preoperative imaging studies did not detect these metastases. Further administration of TA was not performed. Thus, a total 108 hepatectomies in group A and 106 hepatectomies in group B were finally enrolled in this study.
As shown in Table 1 , the most common indication of liver resection was for hepatocellular carcinoma. The liver parenchyma was normal in only 31 cases (14.5%). No significant differences could be found between the 2 groups with regard to patients' background characteristics and operation procedures. The Child-Pugh grades in patients with a diseased liver were also comparable between the groups. There were 87 and 7 Child A and B patients in group A, and 81 and 4 in group B, respectively (P ϭ 0.541). There were also no significant differences between the 2 groups for hepatectomy and concomitant procedures ( Table 2) .
Postoperative results are shown in Table 3 . The extent of liver resection, the resected liver weight, and the area of liver cut surface were not significantly different between the 2 groups. However, the amount of blood loss was significantly reduced in group A, both in liver parenchymal transection and in other part of the operation. Overall, 17 operations (16%) in group B required blood transfusion, while no patient in group A received blood transfusion (P Ͻ 0.0001). The liver transection time, overall liver ischemic time, and total operative time were also significantly reduced in group A. No patients in group A suffered from thromboembolic complications. No hospital mortality occurred in either group. Although postoperative complications and duration of postoperative hospital stay between the 2 groups were comparable, group A had a significantly lower hospital costs than group B (Table 3) .
The preoperative and intraoperative clinicopathologic factors that influenced the blood transfusion rate are shown in Table 4 . Significant clinical factors that influenced blood requirement were tumor size, need for additional procedures, liver transection area, and use of TA. The other variables, including patients' age, sex, hemoglobin level, platelet count, prothrombin time, tumor behavior (benign or malignant), and history of upper abdominal surgery, did not influence the rate of blood transfusion. Although a trend toward higher blood transfusion rate was found in patients with a wide hepatectomy extent, this difference was not statistically significant (P ϭ 0.063).
The characteristics of nontumorous liver parenchyma did not influence the blood transfusion rate. The amounts of blood loss in patients with a normal liver (n ϭ 31) or with a diseased liver (n ϭ 183) were 300 mL (range, 10 -1700 mL) and 400 mL (range, 10 -3140 mL), respectively (P ϭ 0.303). One patient with a normal liver (3.2%) and 16 patients with a diseases liver (8.7%) received blood transfusion (P ϭ 0.477). Moreover, the amounts of operative blood loss in patients with chronic hepatitis (n ϭ 69) and cirrhosis (n ϭ 114) were 450 mL (range, 10 -2550 mL) and 400 mL (range, 10 -3140 mL), respectively (P ϭ 0.577). Blood transfusion in patients with chronic hepatitis and cirrhosis was performed on 5 and 11, respectively (P ϭ 0.788). Backward stepwise logistic regression analysis revealed that the independent factors that significantly reduced the rate of blood transfusion were tumor size Յ 5 cm (odds ratio, 6.951; 95% confidence interval, 0.060 -0.661; P ϭ 0.034) and the use of TA (odds ratio, 1.145; 95% confidence interval, 0.0001-0.0032; P Ͻ 0.0001).
DISCUSSION
Control of hemorrhage remains a mainstay of liver resection. Blood loss in liver resection may occur not only in liver parenchymal transection but also in other parts of the operation, including liver mobilization, dissection of tumor with the surrounding organs, and additional procedures. [2] [3] [4] 14, 15 Liver surgeons have strived to reduce the operative blood loss and avoid blood transfusion in the past 2 decades. 1-14 -20,25 Many strategies, materials, and devices have been proposed to reduce the blood requirement in liver resection, such as preoperative self blood donation with or without use of erythropoietin, 8, 16 intraoperative hemodilution before liver parenchymal transection, 17 use of cell savers, 8 and restrictive blood transfusion policy. 4, 15, 20 Other than conventional finger fracture 3, 4 and clamp crushing techniques, 2, 5, [13] [14] [15] 18, 20 various equipment have been designed to reduce blood loss in liver transection, such as Cavitron ultrasonic aspiration apparatus, 2,4,7-9,25 microwave tissue coagulator, 19 water jet device, 8 and radiofrequency coagulator. 11, 12 Moreover, some devices were adopted to compress liver parenchyma to reduce the operative bleeding in peripheral liver tumor, such as Lin's liver clamp, 3 tourniquets, or needles. 8, 10 Several surgical strategies have been proposed for reducing blood loss (even in cirrhotic liver), such as hepatic inflow occlusion technique 2, 5, [13] [14] [15] 18, 20 and low central venous pressure policy. 4, 5, 20, 37 Besides multiple sutures for bleeding points on liver cut surface, some equipments and coagulation materials, such as argon beam coagulator 8 and fibrin glue, 7, 8, 18 have been developed to facilitate hemostasis of liver cut surface.
However, these strategies and devices involve both advantages and disadvantages. Some strategies are rather complex and difficult to perform. The costs of equipments and materials are often high. Moreover, it is difficult to apply parenchymal compression devices for centrally located tumors. 3, 14 As such, we did not use expensive equipment or complex strategies in liver resection, and the hospital costs of liver resection were substantially saved. The hospital costs in both groups were lower than those reported in other studies regarding liver resection. 1, 16, 17 Liver resection may cause a variable degree of hyperfibrinolytic states. 22, 23 This phenomenon becomes more pronounced in patients with a diseased liver or in patients who have undergone a wider hepatectomy extent. [22] [23] [24] Hyperfibrinolytic activity occurs immediately after hepatectomy and becomes the most accelerated state on the first postoperative day. [22] [23] [24] The effect then gradually returns from the third postoperative day to the preoperative level on postoperative day 7. 23, 24 Therefore, parenteral TA was used to postoperative day 3 in the current study.
This study, which included a large number of patients, investigated a strategy for a "blood transfusion"-free liver resection. Most patients (85.5%) in this series had abnormal liver parenchyma. Control of operative bleeding in a diseased liver is notoriously difficult because of many dilated perihepatic collateral vessels, depressed coagulation factors, and hyperfibrinolysis. [2] [3] [4] [5] 8, [13] [14] [15] 20, [22] [23] [24] Because of our resectional policy in patients with chronic liver disease (wider hepatectomy extent was not performed in poorly functioning liver), the amount of blood loss and blood requirements were not significantly different among those with a normal, a fibrotic, or a cirrhotic liver. In addition, the tumor characteristics (benign or malignant) and presence of tumor symptoms (asymptomatic or symptomatic) did not influence the blood requirement.
While some reports with small patient numbers (most patients with a normal liver) have demonstrated a "blood transfusion"-free liver resection, 11, 12, 20 blood transfusion rates in hepatectomy are generally around 5% to 30%. 1-10 -14 -19,24 The mean amount of blood transfusion was around 1 L in recent reports with a larger study population. 2-4,6 -10,16 -19 In our past experience, [13] [14] [15] using intermittent hepatic inflow blood occlusion technique, low central venous pressure, and restrictive blood transfusion policy, the blood transfusion rate was comparable to other reports. 2-10,16 -19,24 The blood transfusion rate in our group B patients was comparable to that in our recent studies with a similar patient background. 13, 15 Postoperative bleeding, either from operative field or from gastrointestinal tract, is a serious complication after liver resection. [3] [4] [5] 20 Blood transfusion is usually unavoidable in these circumstances. Further life-threatening complications such as jaundice, intra-abdominal abscess, and multiorgan failure may ensue. [3] [4] [5] 20 We applied preoperative sclerotherapy in patients with esophageal varices and used proton inhibitors in patients with peptic ulcer to avoid postoperative gastrointestinal bleeding. 13 The bleeding areas on the liver transection plane and perihepatic area were completely controlled by sutures before closing the abdomen. [13] [14] [15] This strategy helped to ensure that none of the patients in either group suffered from postoperative bleeding requiring a repeat operation.
From our observation, under perioperative administration of TA, operative blood loss was markedly reduced both in liver parenchymal transection phase and other parts of the operation. As in liver resection with aprotinin, 24 we found that, even in patients with a diseased liver, some tiny venous bleeding points could be controlled by compression without the need for sutures due to the antifibrinolytic effect of TA. Small venous bleeding on the liver transection plane could be controlled by bimanual compression during the declamping periods in the cycle of intermittent hepatic inflow blood occlusion. Therefore, parenteral TA makes a "blood transfusion"-free hepatectomy feasible. Furthermore, because of easier bleeding control due to the antifibrinolytic effect of TA, the time span for suturing the bleeding points, and the overall duration of hepatic inflow occlusion and total operation time were markedly reduced in group A.
It may be argued that most of the hepatectomies in this study were not major hepatectomy. Most reports defined major liver resection as Ն3 Couinaud's liver segments. 1,2,4 -12,20 This study also showed a trend of higher blood transfusion rate in patient who had undergone a wider hepatectomy extent. However, because liver resection in a diseased liver should be limited to conserve as much functioning liver parenchyma as possible, 5,13-15 some complex liver resection procedures have been performed for centrally located tumor, such as mesohepatectomy (segmentectomy 4, 5, 8), bisegmentectomy 5, 8; segmentectomy 4; bisegmentectomy 3, 4; and segmentectomy 8. 14 Except for mesohepatectomy, the extent of these resections was less than 3 Couinaud's segments, 3, 5, 36 which was classified as minor hepatectomy in some reports. 1,2,4 -12,20 However, these resections may result in a wider transection plane than conventional major hepatectomies (right or left hepatectomy with or without some extending) 2,4,6,7 because of preservation of bilateral peripheral parts of the liver. 2, 14 Wide transection area usually cause more blood loss and increase the need for blood transfusion. 2, 14, 15 The clinical background, surgical procedures, liver transection area, and extent of liver resection in patients of both groups were not significantly different in this study. The amount of operative blood loss was significantly reduced under the use of TA, which resulted in a zero blood transfusion rate in group A patients. Overall, use of TA was an independent factor of blood requirement in liver resection in the current study.
Tumor size was the other independent factor that influenced the rate of blood transfusion based on our multivariate analysis. Not surprisingly, a large tumor is likely to cause greater blood loss. Large tumors are usually associated with a wide transection plane. 2, 14, 15 They are frequently surrounded by many dilated collateral vessels due to the angiogenic effect. 39 Thus, liver resection of large tumor may cause more blood loss and a higher blood transfusion rate.
The half life of TA was 80 to 120 minutes. 26 The suggested intravenous dose of TA is 10 mg/kg body weight. 26 -32 This dose was used in most reports for cardiac, aortic, and orthopedic surgery as well as liver transplantation. 26 -32 Although the incidence is low, 27-32 a dreadful side effect of this drug is increased risk of thromboembolic effects such as acute myocardial infarction, cerebral embolism, pulmonary embolism, and renal pelvis emboli. 26, 27 The dose and duration that were used in this study were lower than those reported in the aforementioned studies. 26 -32 Perhaps because of dietary and genetic difference, incidence of postoperative thromboembolism after major surgery tends to be lower among Eastern Asians than among whites. 40, 41 At such a low dose, no thromboembolic effect was observed in our group A patients. However, some reports in Western countries have also demonstrated that TA does not increase the risk of this side effect in cardiovascular or orthopedic surgeries. 28 -32 Thromboelastography was first reported by Hartert in 1948. 22 This method can systematically detect the hyperfibrinolytic activity during liver resection within 20 to 30 minutes. 22 Theoretically, it could be used to select patients more accurately to adjust the dose of TA. However, we did not use a thromboelastograph in this study.
In this series, liver transection equipments, hemostatic devices, and coagulation materials were not used because of high cost. We preferred to use the Kelly clamp to transect liver parenchyma to well preserve intrahepatic major vessels (defined as 3 hepatic veins and both portal veins) as demonstrated by Takayama et al. 18 Moreover, in addition to lower costs of "Surgicel" and TA used in this series, with a zero blood transfusion rates and shorter operation time, the overall hospital costs in group A were significantly reduced compared with group B.
CONCLUSION
Perioperative intravenous administration of TA is worthwhile to reduce the amount of blood loss and the need for blood transfusion in elective liver tumor resection. With the assistance of parenteral TA, blood transfusion in elective liver resection could become rare. It will be easier to approach in Western country where most hepatectomy is performed on a normal liver. A genuine "blood transfusion"-free liver resection will be feasible without the need for expensive equipment.
